Antithrombotic Agent

DRUG2 trials

Sponsors

Oslo University Hospital, Scientific Institute San Raffaele

Conditions

Anticoagulant-Induced BleedingAnticoagulant-induced BleedingAtrial FibrillationCerebral HemorrhageCoronary DiseaseIntracranial HemorrhagesMyocardial InfarctionSecondary Prevention

Phase 4

Study of Antithrombotic Treatment After IntraCerebral Haemorrhage

TerminatedNCT03186729

Oslo University HospitalAnticoagulant-Induced Bleeding, Atrial Fibrillation, Cerebral Hemorrhage +2

Start: 2018-07-01End: 2024-08-31Updated: 2025-02-12

Unknown Phase

Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)

Scientific Institute San RaffaeleAnticoagulant-induced Bleeding, Atrial Fibrillation, Coronary Disease +1

Start: 2020-01-25End: 2022-09-30Target: 1500Updated: 2020-03-26

Related Papers

Study of Antithrombotic Treatment After Intracerebral Hemorrhage-Antiplatelets: A Randomized Trial.

2026-06-18

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial.

2019-05-22128 citations

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial.

2019-05-2263 citations